Search

Your search keyword '"Paolo M. Moretti"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Paolo M. Moretti" Remove constraint Author: "Paolo M. Moretti"
27 results on '"Paolo M. Moretti"'

Search Results

1. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

2. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

3. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

4. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

5. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

6. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

7. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

8. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

9. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

10. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

11. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

12. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

13. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

14. Does persistence pay off? Accessing social activities with a foreign-sounding name

15. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

16. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

17. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

18. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

19. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3

20. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

21. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

22. IRF2BPL Is Associated with Neurological Phenotypes

23. A Comprehensive Iterative Approach is Highly Effective in Diagnosing Individuals who are Exome Negative

24. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases

25. MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome

26. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype

27. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

Catalog

Books, media, physical & digital resources